Manojkumar Bupathi
Impact in
Papers in
- Co-authors
- Daniel P. Petrylak (14 shared papers)Scott T. Tagawa (14 shared papers)Petros Grivas (14 shared papers)Yohann Loriot (14 shared papers)Cora N. Sternberg (14 shared papers)Philippe Barthélémy (11 shared papers)Damien Pouessel (11 shared papers)Aude Fléchon (11 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Annals of Oncology (5 papers)The Oncologist (1 paper)Medical Oncology (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Manojkumar Bupathi
42 papers receiving 837 citations
Manojkumar Bupathi's Hit Papers
Peers
Comparison fields: 5 of 59
- Oncology 389
- Surgery 403
- Cancer Research 66
- Hepatology 34
- Pulmonary and Respiratory Medicine 126
Countries citing papers authored by Manojkumar Bupathi
This map shows the geographic impact of Manojkumar Bupathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manojkumar Bupathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manojkumar Bupathi more than expected).
Fields of papers citing papers by Manojkumar Bupathi
This network shows the impact of papers produced by Manojkumar Bupathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manojkumar Bupathi. The network helps show where Manojkumar Bupathi may publish in the future.
Co-authors
The 25 scholars most cited alongside Manojkumar Bupathi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors Hit paper breakdown → | 2021 | 367 |
| 2 | 2015 | 61 | |
| 3 | 2016 | 47 | |
| 4 | TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes Hit paper breakdown → | 2024 | 45 |
| 5 | 2024 | 37 | |
| 6 | 2019 | 31 | |
| 7 | 2022 | 30 | |
| 8 | 2014 | 28 | |
| 9 | 2020 | 19 | |
| 10 | 2023 | 15 | |
| 11 | 2020 | 15 | |
| 12 | 2017 | 14 | |
| 13 | 2023 | 13 | |
| 14 | 2023 | 12 | |
| 15 | 2024 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2024 | 10 | |
| 18 | 2017 | 9 | |
| 19 | 2016 | 9 | |
| 20 | 2017 | 8 |
About Manojkumar Bupathi
Manojkumar Bupathi is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Pathology and Forensic Medicine, having authored 46 papers that have together received 850 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (21 papers), Cancer Immunotherapy and Biomarkers (19 papers), Multiple and Secondary Primary Cancers (6 papers), Renal cell carcinoma treatment (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Prostate Cancer Treatment and Research (5 papers), Urinary and Genital Oncology Studies (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Oncology (389 citations), Surgery (403 citations), Cancer Research (66 citations), Hepatology (34 citations) and Pulmonary and Respiratory Medicine (126 citations). Manojkumar Bupathi has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Daniel P. Petrylak, Scott T. Tagawa, Petros Grivas, Yohann Loriot, Cora N. Sternberg, Philippe Barthélémy, Damien Pouessel, Aude Fléchon, Neeraj Agarwal and Arjun Vasant Balar. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Medical Oncology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.